Wanrudee Isaranuwatchai


Affiliate Scientist


Dr. Wanrudee Isaranuwatchai is an Affiliated Scientist at St. Michael’s Hospital, and an Associate Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto, in Canada. She is also a Program Leader and Senior Researcher of the Health Intervention and Technology Assessment Program (HITAP), Thailand.

Her research focuses on how to apply health economics and health technology assessment (HTA) in the real-world setting as well as how to advance methods in economic evaluation (EE). She has experience conducting EEs using various methods with specific interest in the potential of big data in health economics and HTA to support evidence generation and policy-making process.

She has also collaborated with researchers, health professionals, and policy-makers in various areas to help communicate the value of health initiatives using EE. She has contributed to the training on HTA to support health systems in Asia, Africa, and North America. Dr. Isaranuwatchai is dedicated to the creation and use of evidence in healthcare decision making.

Recent Publications

  1. Bakhache, N, Shirreff, L, Matelski, J, Loong, D, Isaranuwatchai, W, Murji, A et al.. Impact of Preoperative Anemia on the Healthcare Cost of a Hysterectomy. J Obstet Gynaecol Can. 2023; :102230. doi: 10.1016/j.jogc.2023.102230. PubMed PMID:37741617 .
  2. Kc, S, Lin, LW, Bayani, DBS, Zemlyanska, Y, Adler, A, Ahn, J et al.. What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward. Int J Health Policy Manag. 2023;12 :6858. doi: 10.34172/ijhpm.2023.6858. PubMed PMID:37579427 PubMed Central PMC10461954.
  3. Shickh, S, Mighton, C, Clausen, M, Kodida, R, Adi-Wauran, E, Hirjikaka, D et al.. "I don't need any more unknowns hanging over my head": Cancer patients' views on variants of uncertain significance and low/moderate risk results from genomic sequencing. Genet Med. 2023; :100960. doi: 10.1016/j.gim.2023.100960. PubMed PMID:37577963 .
  4. Veroniki, AA, Soobiah, C, Nincic, V, Lai, Y, Rios, P, MacDonald, H et al.. Efficacy of sustained knowledge translation (KT) interventions in chronic disease management in older adults: systematic review and meta-analysis of complex interventions. BMC Med. 2023;21 (1):269. doi: 10.1186/s12916-023-02966-9. PubMed PMID:37488589 PubMed Central PMC10367354.
  5. Akksilp, K, Koh, JJE, Tan, V, Tong, EH, Budtarad, N, Xueying, G et al.. The physical activity at work (PAW) study: a cluster randomised trial of a multicomponent short-break intervention to reduce sitting time and increase physical activity among office workers in Thailand. Lancet Reg Health Southeast Asia. 2023;8 :100086. doi: 10.1016/j.lansea.2022.100086. PubMed PMID:37384135 PubMed Central PMC10305858.
  6. Luangasanatip, N, Painter, C, Pan-Ngum, W, Saralamba, S, Wichaita, T, White, L et al.. How to model the impact of vaccines for policymaking when the characteristics are uncertain: A case study in Thailand prior to the vaccine rollout during the COVID-19 pandemic. Vaccine. 2023;41 (33):4854-4860. doi: 10.1016/j.vaccine.2023.06.055. PubMed PMID:37365059 PubMed Central PMC10281228.
  7. Sukmanee, J, Butchon, R, Karunayawong, P, Dabak, SV, Isaranuwatchai, W, Teerawattananon, Y et al.. The impact of universal health coverage and COVID-19 pandemic on out-of-pocket expenses in Thailand: an analysis of household survey from 1994 to 2021. Expert Rev Pharmacoecon Outcomes Res. 2023;23 (7):823-830. doi: 10.1080/14737167.2023.2219447. PubMed PMID:37272480 .
  8. Kodida, R, Reble, E, Clausen, M, Shickh, S, Mighton, C, Sam, J et al.. A model for the return and referral of all clinically significant secondary findings of genomic sequencing. J Med Genet. 2023;60 (8):733-739. doi: 10.1136/jmg-2022-109091. PubMed PMID:37217257 .
  9. Luankongsomchit, V, Boonma, C, Soboon, B, Ranron, P, Isaranuwatchai, W, Pimsarn, N et al.. How Many People Experience Unsafe Medical Care in Thailand, and How Much Does It Cost under Universal Coverage Scheme?. Healthcare (Basel). 2023;11 (8):. doi: 10.3390/healthcare11081121. PubMed PMID:37107954 PubMed Central PMC10137567.
  10. Mendlowitz, AB, Bremner, KE, Krahn, M, Walker, JD, Wong, WWL, Sander, B et al.. Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study. CMAJ. 2023;195 (14):E499-E512. doi: 10.1503/cmaj.220717. PubMed PMID:37040993 PubMed Central PMC10089629.
Search PubMed

Affiliations & Other Activities

  • Scientist, Li Ka Shing Institute
  • Assistant Professor, Institute for Health Policy, Management and Evaluation, University of Toronto